Highlights and Quick Summary
- EBITDA for the quarter ending March 31, 2023 was $-4.31 Million (a -22.63% decrease compared to previous quarter)
- Year-over-year quarterly EBITDA decreased by -7.83%
- Annual EBITDA for 2022 was $-17.7 Million (a 1.29% increase from previous year)
- Annual EBITDA for 2022 was $-17.5 Million (a 30.65% increase from previous year)
- Annual EBITDA for 2021 was $-13.4 Million (a 1.47% increase from previous year)
- Twelve month EBITDA ending March 31, 2023 was $-19 Million (a 5.33% increase compared to previous quarter)
- Twelve month trailing EBITDA increased by 8.31% year-over-year
Trailing EBITDA for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| $-19 Million | $-18.1 Million | $-17.3 Million | $-17.6 Million |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBITDA of Benitec Biopharma Limited
Most recent EBITDAof BNTC including historical data for past 10 years.Interactive Chart of EBITDA of Benitec Biopharma Limited
Benitec Biopharma Limited EBITDA for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-4.31 | – | – | – | – |
| 2022 | $-5.57 | $-4.48 | $-4.68 | $-3.35 | $-17.69 |
| 2021 | $-4.78 | $-4.77 | $-3.8 | $-3.73 | $-13.37 |
| 2020 | $-3.19 | $-2.65 | $-2.85 | $-2.06 | $-8.09 |
| 2019 | – | – | $-2.06 | $-1.12 | $2.74 |
| 2018 | – | – | – | – | $-8.81 |
| 2017 | – | – | – | $-2.21 | $-4.08 |
| 2016 | – | – | – | $0.75 | $-15.36 |
| 2015 | – | – | – | – | $-8.66 |
| 2014 | – | – | – | – | $-6.77 |
| 2013 | – | – | – | – | $-3.57 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology